II. Pathophysiology

  1. Cancer Antigen 19-9 is expressed in pancreatic disease and hepatobiliary disease

III. Indications

  1. Pancreatic ductal adenocarcinoma
    1. Confirms diagnosis
    2. Predicts prognosis as well as recurrence risk
  2. Not indicated for screening in asymptomatic patients
    1. No tumor specific (see efficacy below)

IV. Causes: Increased CA 19-9

  1. Pancreatic Ductal Adenocarcinoma
  2. Chronic Pancreatitis
  3. Chronic inflammatory states

V. Efficacy: Pancreatic Ductal Adenocarcinoma

Images: Related links to external sites (from Bing)

Related Studies